Literature DB >> 4114451

Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis.

A G Vagenakis, R Cote, M E Miller, L E Braverman, F Stohlman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4114451

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN： 0021-7263


× No keyword cloud information.
  5 in total

1.  Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.

Authors:  K A Woeber; I Warner
Journal:  West J Med       Date:  1999-01

2.  A population-based assessment of the drug interaction between levothyroxine and warfarin.

Authors:  D Pincus; T Gomes; C Hellings; H Zheng; J M Paterson; M M Mamdani; D N Juurlink
Journal:  Clin Pharmacol Ther       Date:  2012-10-24       Impact factor: 6.875

Review 3.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

4.  Extremely elevated international normalized ratio of warfarin in a patient with CYP2C9*1/*3 and thyrotoxicosis.

Authors:  Ji Eun Lee; Duck Hyun Ryu; Ho Jung Jeong; Jung Hoon Kim; Ji Eun Jun; June Soo Kim; Soo Youn Lee
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

5.  Graves' disease and treatment effects on warfarin anticoagulation.

Authors:  Amanda Howard-Thompson; Alexis Luckey; Christa George; Beth A Choby; Timothy H Self
Journal:  Case Rep Med       Date:  2014-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.